AR078126A1 - Antagonistas de glicina b, composiciones farmaceuticas, usos y proceso de preparacion de los mismos - Google Patents

Antagonistas de glicina b, composiciones farmaceuticas, usos y proceso de preparacion de los mismos

Info

Publication number
AR078126A1
AR078126A1 ARP100101979A ARP100101979A AR078126A1 AR 078126 A1 AR078126 A1 AR 078126A1 AR P100101979 A ARP100101979 A AR P100101979A AR P100101979 A ARP100101979 A AR P100101979A AR 078126 A1 AR078126 A1 AR 078126A1
Authority
AR
Argentina
Prior art keywords
alkyl
6alkyl
aryl
heteroaryl
6alkoxy
Prior art date
Application number
ARP100101979A
Other languages
English (en)
Inventor
Markus Henrich
Ginta Grunsteine
Jens Nagel
Valerjans Kauss
Angela Bauer
Jevgenijs Rozhkovs
Dina Trifanova
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of AR078126A1 publication Critical patent/AR078126A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51—Y being a hydrogen or a carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/16—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same carbon atom of an acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C07C255/44—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms at least one of the singly-bound nitrogen atoms being acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Derivados de naftaleno y sus sales farmacéuticamente aceptables y proceso para la preparacion de dichos compuestos. Los compuestos de la solicitud son antagonistas de glicina B y por lo tanto son utiles para el control y prevencion de diferentes trastornos, incluyendo trastornos neurologicos. Reivindicacion 1: Un compuesto caracterizado porque se selecciona entre los de la formula (1) donde R1 representa hidrogeno, halogeno, nitro, acilamino, trifluorometilo, alquilo C1-6, alcoxi C1-6, hidroxi-C1-6alquilo, o alcoxi C1-6-alquilo C1-6; R2 representa hidrogeno, halogeno, nitro, trifluorometilo, alquilo C1-6, o alcoxi C1-6; R3 representa halogeno, nitro, trifluorometilo, o alquilo C1-6; R4 representa hidrogeno, CONH2, aIquilo C1-6, alquenilo C3-6, alquinilo C3-6, hidroxi-C1-6alquilo, carboxi-C1-6aIquilo, alcoxi C1-6-alquilo C1-6, carbamoil-C1-6alquilo, arilo, heteroarilo, ciclo-C3-12alquilo, ciclo-C3-12alquil-C1-6alquilo, ciclo-C3-12alcoxi-C1-6alquilo, aril-C1-6alquilo, heteroaril-C1-6alquilo, ariloxi-C1-6alquilo, heteroariloxi-C1-6alquilo, aril-C1-6aIcoxi-C1-6alquilo, heteroaril-C1-6aIcoxi-C1-6alquilo, arilamino-C1-6alquilo, heteroarilamino-C1-6alquilo, ciclo-C3-12alquil-amino-C1-6alquilo, alquilaminocarbonil C1-6-alquilo C1-6, ciclo-C3-12alquilaminocarbonil-C1-6alquilo, arilaminocarbonil-C1-6alquilo, heteroarilaminocarbonil-C1-6aIquilo, carboxi-C1-6alquilamino-C1-6alquilo, acilamino-C1-6aIquilo; arilsulfonilamino-C1-6alquilo, alquilsulfonilamino C1-6-alquilo C1-6, ciclo-C3-12aIquil-C1-6alquilaminocarbonil-C1-6alquilo, aril-C1-6alquilaminocarbonil-C1-6alquilo, heteroaril-C1-6alquilaminocarbonil-C1-6alquilo, hidroxi-C1-6alquilaminocarbonil-C1-6alquilo, di-(alquil C1-6)aminocarbonil-C1-6alquilo, aril(alquil C1-6)aminocarbonil-C1-6alquilo, o heteroaril(alquil C1-6)aminocarbonil-C1-6alquilo; R5 representa hidrogeno o alquilo C1-6; R6 representa hidroxi, alcoxi C1-6, hidroxi-C1-6aIcoxi, arilo, heteroarilo, o NR7R8; R7 y R8, que pueden ser iguales o diferentes, representan en forma independiente entre sí hidrogeno, aIquilo C1-6, alquenilo C3-6, alquinilo C3-6, alquilamino C1-6, arilamino, di(alquil C1-6)amino, aril(alquil C1-6)amino, alcoxicarbonilo C1-6, alquilsulfonilo C1-6, arilsulfonilo, heteroarilsulfonilo, alquil C1-6-carbamoilo, ciclo-3-12alquilaminocarbonilo, arilaminocarbonilo, heteroarilaminocarbonilo, di-(alquil C1-6)aminocarbonilo, aril(alquil C1-6)aminocarbonilo, heteroaril(alquil C1-6)aminocarbonilo, hidroxi-C1-6alquilo, hidroxi(aril)-C1-6aIquilo, carboxi-C1-6alquilo, alcoxicarbonil C1-6-alquilo C1-6, carboxi(aril)-C1-6alquilo, carboxi(aril-C1-6alquil)-C1-6alquilo, alcoxi C1-6-alquilo C1-6, carbamoil-C1-6alquilo, arilo, heteroarilo, ciclo-C3-12alquilo, ciclo-C3-12alquil-C1-6aIquilo, aril-C1-6alquilo, heteroaril-C1-6alquilo, aril-ciclo-C3-12alquilo, heteroaril-ciclo-C3-12alquilo, ciclo-C3-12alcoxi-C1-6alquilo, ariloxi-C1-6alquilo, heteroariloxi-C1-6alquilo, aril-C1-6alcoxi-C1-6aIquilo, heteroaril-C1-6aIcoxi-C1-6aIquilo, arilamino-C1-6alquilo, heteroarilamino-C1-6alquilo, ciclo-C3-12alquilamino-C1-6alquilo, alquilaminocarbonil C1-6-alquilo C1-6, ciclo-C3-12alquilaminocarbonil-C1-6alquilo, arilaminocarbonil-C1-6alquilo, heteroarilaminocarbonil-C1-6aIquilo, carboxi-C1-6alquilamino-C1-6alquilo, acilamino-C1-6aIquilo; aIquilsulfonilamino C1-6-alquilo C1-6, arilsulfonilamino-C1-6alquilo, ciclo-C3-12alquil-C1-6alquilaminocarbonil-C1-6alquilo, aril-C1-6alquilaminocarbonil-C1-6alquilo, heteroaril-C1-6aIquilaminocarbonil-C1-6alquilo, hidroxi-C1-6alquilaminocarbonil-C1-6aIquilo, di-(alquil C1-6)aminocarbonil-C1-6alquilo, aril(alquil C1-6)aminocarbonil-C1-6aIquilo, o heteroaril(alquil C1-6)aminocarbonil-C1-6aIquilo; o R7 y R8 juntos representan -(CH2)n- donde n es 3, 4, o 6; o R7 y R8 junto con el átomo de nitrogeno al cual están unidos representan un anillo de 4, 5, 6 o 7 miembros que puede estar saturado o insaturado, donde, además del átomo de nitrogeno, el anillo puede contener un heteroátomo adicional seleccionado entre azufre, oxígeno y nitrogeno y/o puede condensarse a un anillo aromático o heteroaromático seleccionado entre fenilo, furilo, tienilo, pirrolilo, oxazolilo, isoxazolilo, tiazolilo, imidazolilo, pirazolilo, oxadiazolilo, tiadiazolilo, tetrazolilo, piridinilo, pirimidinilo, pirazinilo, piridazinilo, y donde el anillo puede estar opcionalmente sustituido con uno o más sustituyentes seleccionados entre halogeno, hidroxi, nitro, acilamino, trifluorometilo, alquilo C1-6, alcoxi C1-6, hidroxi-C1-6alquilo, alcoxi C1-6-aIquilo C1-6, COOH, CONH2, alcoxicarbonilo C1-6, alquilaminocarbonilo C1-6, arilaminocarbonilo, heteroarilaminocarbonilo, di-(alquil C1-6)aminocarbonilo, carboxi-C1-6alquilo, alcoxicarbonil C1-6-aIquilo C1-6, carbamoil-C1-6alquilo, ciclo-C3-12alquilo, arilo, heteroarilo, aril-C1-6alquilo, y heteroaril-C1-6alquilo; o R4 y R7 junto con los átomos de carbono y nitrogeno a los cuales están unidos representan un anillo de 5 o 6 miembros, donde el anillo puede estar opcionalmente sustituido con uno o más sustituyentes seleccionados entre alquilo C1-6, arilo, heteroarilo, COOH, alcoxicarbonilo C1-6, y CONH2; donde el término ôariloö representa fenilo o naftilo, o fenilo sustituido con uno o más sustituyentes seleccionados entre halogeno, amino, hidroxi, nitro, ciano, COOH, CONH2, alquilaminocarbonilo C1-6, arilaminocarbonilo, heteroarilaminocarbonilo, hidroxi-C1-6alquilaminocarbonilo, di-(alquil C1-6)aminocarbonilo, trifluorometilo, aIquilo C1-6, heteroarilo, alcoxi C1-6, difluorometoxi, trifluorometoxi, ciclo-C3-12alcoxi, ariloxi, heteroariloxi, aril-C1-6alcoxi, heteroaril-C1-6alcoxi, amino-C1-6alquilo, hidroxi-C1-6alquilo, carboxi-C1-6alquilo, carbamoil-C1-6alquilo, ciano-C1-6alquilo, alcoxicarbonilamino C1-6-alquilo C1-6, hidroxi-C1-6alcoxi, carboxi-C1-6alcoxi, acil-C1-6alcoxi, alcoxicarbonilo C1-6, alquilamino C1-6, ciclo-C3-12alquilamino, arilamino, heteroarilamino, aril-C1-6alquilamino, heteroaril-C1-6alquilamino, hidroxi-C1-6alquilamino, carboxi-C1-6alquilamino, di-(alquil C1-6)amino, acilamino, di-(alquil C1-6)amino-C1-6alquilo, di-(alquil C1-6)amino-C1-6alquilamino-C1-6aIquilo, heterociclil-C1-6alquilo, alcoxicarbonil C1-6-alquilo C1-6, heterociclil-C1-6alquilo, ciano-C1-6alcoxi, heterociclil-C1-6aIcoxi, alquilamino C1-6-alcoxi C1-6, di-(alquil C1-6)amino-C1-6alcoxi, carboxi-C1-6alquilamino-C1-6alcoxi, alcoxicarbonil C1-6-alcoxi C1-6, heteroarilaminocarbonilC1-6alcoxi, alquilsulfonilamino C1-6, arilsulfonilamino, alquil C1-6-aminosulfonilo, di-(alquil C1-6)aminosulfonilo, arilaminosulfonilo, heteroarilaminosulfonilo, alquilaminocarbonil C1-6-alquilo C1-6, ciclo-C3-12alquilaminocarbonil-C1-6alquilo, arilaminocarbonil-C1-6alquilo, heteroarilaminocarbonil-C1-6alquilo, hidroxiC1-6alquilaminocarbonil-C1-6alquilo, carboxi-C1-6alquilaminocarbonil-C1-6alquilo, y di-(alquil C1-6)aminocarbonil-C1-6alquilo; y el término ôheteroariloö representa un anillo aromático de 5 o 6 miembros que comprende entre uno y cuatro heteroátomos seleccionados entre oxígeno, azufre y nitrogeno, o un grupo bicíclico que contiene un anillo de 5 o 6 miembros que comprende entre uno y cuatro heteroátomos seleccionados entre oxígeno, azufre y nitrogeno fusionado con un anillo benceno o con un anillo de 5 o 6 miembros que comprende entre uno y cuatro heteroátomos seleccionados entre oxígeno, azufre y nitrogeno, donde el heteroarilo está opcionalmente sustituido con uno o más sustituyentes seleccionados entre halogeno, amino, hidroxi, nitro, ciano, COOH, CONH2, alquilaminocarbonilo C1-6, arilaminocarbonilo, heteroarilaminocarbonilo, hidroxi-C1-6alquilaminocarbonilo, di-(alquil C1-6)aminocarbonilo, trifluorometilo, alquilo C1-6, heteroarilo, alcoxi C1-6, difluorometoxi, trifluorometoxi, ciclo-C3-12alcoxi, ariloxi, heteroariloxi, aril-C1-6alcoxi, heteroaril-C1-6alcoxi, amino-C1-6alquilo, hidroxi-C1-6alquilo, carboxi-C1-6alquilo, carbamoil-C1-6alquilo, ciano-C1-6aIquilo, alcoxicarbonilamino C1-6-alquilo C1-6, hidroxi-C1-6alcoxi, carboxi-C1-6alcoxi, acil-C1-6alcoxi, alcoxicarbonilo C1-6, alquilamino C1-6, ciclo-C3-12alquilamino, arilamino, heteroarilamino, aril-C1-6alquilamino, heteroaril-C1-6alquilamino, hidroxi-C1-6alquilamino, carboxi-C1-6alquilamino, di-(alquil C1-6)amino, acilamino, di-(alquil C1-6)amino-C1-6alquilo, di-(alquil C1-6)amino-C1-6aIquilamino-C1-6alquilo, heterociclil-C1-6alquilo, alcoxicarbonil C1-6-alquilo C1-6, heterociclil-C1-6alquilo, ciano-C1-6alcoxi, heterociclil-C1-6alcoxi, alquilamino C1-6-alcoxi C1-6, di-(alquil C1-6)amino-C1-6alcoxi, carboxi-C1-6alquilamino-C1-6alcoxi, alcoxicarbonil C1-6-alcoxi C1-6, heteroarilaminocarbonil-C1-6alcoxi, alquilsulfonilamino C1-6, arilsulfonilamino, alquil C1-6-aminosulfonilo, di-(alquil C1-6)aminosulfonilo, arilaminosulfonilo, heteroarilaminosulfonilo, alquilaminocarbonil C1-6-alquilo C1-6, ciclo-C3-12alquilaminocarbonil-C1-6alquilo, arilaminocarbonil-C1-6aIquilo, heteroarilaminocarbonil-C1-6aIquilo, hidroxi-C1-6alquilaminocarbonil-C1-6alquilo, carboxi-C1-6alquilaminocarbonil-C1-6alquilo, y di-(alquil C1-6)aminocarbonil-C1-6alquilo; e isomeros opticos, polimorfos, análogos, derivados, prodrogas y sales de adicion ácida y básica e hidratos y solvatos farmacéuticamente aceptables del mismo. Reivindicacion 12: Una composicion farmacéutica, caracterizada porque comprende como principio activo un compuesto como se reivindica en cualquiera de las reivindicaciones precedentes, opcionalmente junto con uno o más excipientes farmacéuticamente aceptables. Reivindicacion 15: Uso de un compuesto como se reivindica en cualquiera de las reivindicaciones 1 a 11, caracterizado porque es para la fabricacion de un medicamento para el tratamiento o prevencion de una condicion que se selecciona de: dolor, incluyendo dolor agudo, dolor cronico, alodinia, hiperalgesia, dolor visceral, dolor fantasma, dolor postoperatorio, dolor neuropático, neuropatía periférica incluyendo, por ejemplo neuropatía periférica inducida por nocicepcion, inflamacion, isquemia, infeccion viral (HZV), lesion de nervi
ARP100101979A 2009-06-04 2010-06-04 Antagonistas de glicina b, composiciones farmaceuticas, usos y proceso de preparacion de los mismos AR078126A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21777709P 2009-06-04 2009-06-04
EP09007401 2009-06-04

Publications (1)

Publication Number Publication Date
AR078126A1 true AR078126A1 (es) 2011-10-19

Family

ID=41092044

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100101979A AR078126A1 (es) 2009-06-04 2010-06-04 Antagonistas de glicina b, composiciones farmaceuticas, usos y proceso de preparacion de los mismos

Country Status (5)

Country Link
US (1) US20120220577A1 (es)
EP (1) EP2438037A1 (es)
AR (1) AR078126A1 (es)
TW (1) TW201109016A (es)
WO (1) WO2010139481A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013030358A1 (en) 2011-08-31 2013-03-07 Merz Pharma Gmbh & Co. Kgaa Glycine b antagonists
US9249085B2 (en) 2011-09-16 2016-02-02 Fovea Pharmaceuticals Aniline derivatives, their preparation and their therapeutic application
JP2015527403A (ja) * 2012-09-11 2015-09-17 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． Ｈｉｖプロテアーゼ阻害剤
CN109562113A (zh) 2016-05-10 2019-04-02 C4医药公司 用于靶蛋白降解的螺环降解决定子体
CN106622375B (zh) * 2016-12-17 2019-06-04 聊城大学 一种2,4-二羟基苯甲醛缩氨基酸镍催化剂、制备方法及应用
EP3366683A1 (en) 2017-02-28 2018-08-29 Acousia Therapeutics GmbH Cyclic amides, acteamides and ureas useful as potassium channel openers
WO2022087433A1 (en) * 2020-10-23 2022-04-28 Dana-Farber Cancer Institute, Inc. Covalent inhibitors of creatine kinase (ck) and uses thereof for treating and preventing cancer
CN114163396B (zh) * 2021-12-14 2022-10-04 北京阳光诺和药物研究股份有限公司 一种依帕司他中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4275076A (en) * 1980-02-04 1981-06-23 American Cyanamid Company Substituted naphthoic acids
DE10306202A1 (de) * 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
DE10306203A1 (de) * 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen

Also Published As

Publication number Publication date
WO2010139481A1 (en) 2010-12-09
EP2438037A1 (en) 2012-04-11
TW201109016A (en) 2011-03-16
US20120220577A1 (en) 2012-08-30

Similar Documents

Publication Publication Date Title
AR078126A1 (es) Antagonistas de glicina b, composiciones farmaceuticas, usos y proceso de preparacion de los mismos
CO2023008167A2 (es) Inhibidores de prmt5
UA109698C2 (xx) Похідні азаіндазолу або діазаіндазолу як медикамент
BR112015029512A2 (pt) derivados de pirazolopirrolidina e seu uso no tratamento de doenças
PE20151749A1 (es) Compuestos amida para el tratamiento del vih
UA106057C2 (uk) Спосіб одержання сполук дигідроінденаміду, фармацевтична композиція, що містить дані сполуки, та їх застосування як інгібітора протеїнкінази
UY37160A (es) COMPUESTOS DERIVADOS DE PIRROLIDINA CON ACTIVIDAD ANTAGONISTA DE INTEGRINA avß6
AR079208A2 (es) Inhibidores de la actividad de proteina tirosina quinasa, composicion y uso de dichos inhibidores para la preparacion de un medicamento para tratar una enfermedad, trastorno o condicion oftalmica
CO2023007504A2 (es) Derivados de carboxamida tricíclica como inhibidores de prmt5
JP2019504050A5 (es)
EA201891267A1 (ru) Фармацевтическая композиция, содержащая действенный ингибитор urat1
PE20161432A1 (es) Compuestos y composiciones para inducir condrogenesis
CY1124245T1 (el) Τρικυκλικα συγχωνευμενα παραγωγα πυριδινης-2-ενα και η χρηση τους ως αναστολεις brd4
UY37837A (es) Nuevos compuestos heterocíclicos como inhibidores de cdk8/19
CY1124346T1 (el) ΠΑΡΑΓΩΓΑ ΧΡΩΜΑΝΙΟΥ, ΙΣΟΧΡΩΜΑΝΙΟΥ ΚΑΙ ΔΙΥΔΡΟΪΣΟΒΕΝΖΟΦΟΥΡΑΝΙΟΥ ΩΣ mGluR2-APNHTIKOI ΑΛΛΟΣΤΕΡΙΚΟΙ ΔΙΑΜΟΡΦΩΤΕΣ, ΣΥΝΘΕΣΕΙΣ, ΚΑΙ ΧΡΗΣΗ ΑΥΤΩΝ
RU2013127655A (ru) Фармацевтическая комбинация паклитаксела и ингибитора cdk
CO2018001700A2 (es) Derivados de n-[1h-bencimidazol-2-il] metil-pirazin-2-il-carboxamida, composiciones y procedimientos de preparación de los mismos
EA202190586A1 (ru) N-замещенные диоксоциклобутениламино-3-гидроксипиколинамиды, приемлемые в качестве ингибиторов ccr6
AR073331A1 (es) DERIVADOS DE QUINOLEíNA, COMPOSICIoN FARMACÉUTICA QUE LOS COMPRENDE Y SU USO EN EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR EL ANTAGONISMO DE GLICINA B.
UY36123A (es) Derivados de carboxamida
FI3643718T3 (fi) Heterosyklinen yhdiste ja sen käyttö kolinergisen muskariini-m1-reseptorin positiivisena allosteerisena modulaattorina
DOP2022000054A (es) Inhibidor de irak y método de preparación para el mismo y uso del mismo
ECSP099602A (es) Sales de adición de ácido, hidratos y polimorfos de la etil-amida del ácido 5-(2,4-dihidroxi-5-isopropil-fenil)-4-(4-morfolin-4-il-metil-fenil)-isoxazol-3-carboxílico, y formulaciones que comprenden estas formas
PE20151607A1 (es) Formulaciones de compuestos organicos
CL2020002188A1 (es) Compuestos de dihidropirimidinona o dihidrotriazinona fusionados con anillos saturados y su uso farmacéutico.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal